Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 0 | 0 | 312 | 528 | 7,031 |
| Gross Profit | N/A | N/A | 312 | 528 | 7,031 |
| Operating Expenses | 12,800 | 11,456 | 57,511 | 7,931 | 13,172 |
| Operating Income | -12,800 | -11,456 | -57,199 | -7,403 | -6,141 |
| Other Income | 1,072 | 118 | 7,216 | 10 | 47 |
| Pre-tax Income | -11,728 | -11,338 | -49,983 | -7,393 | -6,094 |
| Net Income Continuous | -11,728 | -11,338 | -49,983 | -7,393 | -6,094 |
| Net Income | $-11,728 | $-11,338 | $-49,983 | $-7,393 | $-6,094 |
| EPS Basic Total Ops | -0.34 | -9.34 | -5.07 | -0.95 | -0.81 |
| EPS Basic Continuous Ops | -0.34 | 0.08 | -5.07 | -0.95 | -0.81 |
| EPS Diluted Total Ops | -0.34 | -9.34 | -5.07 | -0.95 | -0.81 |
| EPS Diluted Continuous Ops | -0.34 | 0.08 | -5.07 | -0.95 | -0.81 |
| EBITDA(a) | $-12,783 | $-11,439 | $-57,077 | $-7,117 | $-5,846 |